G. Kenneth Lloyd
- Molecular Biology top 5%
- Cellular and Molecular Neuroscience top 2%
- Pharmacology top 1%
- Organic Chemistry top 5%
- Oncology top 10%
- Co-authors
- Michael WilliamsFrédérique MenzaghiMichael A. PalladinoTadimeti S. RaoSaskia NeuteboomBarbara C. M. PottsAida SacaanKin S. Lam
- Topics
- Nicotinic Acetylcholine Receptors Study (24 papers)Ubiquitin and proteasome pathways (21 papers)Cholinesterase and Neurodegenerative Diseases (12 papers)
- Partner nations
- United StatesAustraliaSwitzerland
In The Last Decade
G. Kenneth Lloyd
79 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 116
- Molecular Biology 2.1k
- Cellular and Molecular Neuroscience 728
- Pharmacology 727
- Organic Chemistry 502
- Oncology 333
Countries citing papers authored by G. Kenneth Lloyd
This map shows the geographic impact of G. Kenneth Lloyd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Kenneth Lloyd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Kenneth Lloyd more than expected).
Fields of papers citing papers by G. Kenneth Lloyd
This network shows the impact of papers produced by G. Kenneth Lloyd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Kenneth Lloyd. The network helps show where G. Kenneth Lloyd may publish in the future.
Co-authorship network of co-authors of G. Kenneth Lloyd
This figure shows the co-authorship network connecting the top 25 collaborators of G. Kenneth Lloyd. A scholar is included among the top collaborators of G. Kenneth Lloyd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Kenneth Lloyd. G. Kenneth Lloyd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 24 | |
| 2 | 107 | |
| 3 | 41 | |
| 4 | 24 | |
| 5 | 25 | |
| 6 | 66 | |
| 7 | 51 | |
| 8 | 13 | |
| 9 | Phase 1 clinical trials of NPI-2358 (a novel vascular disrupting agent) in patients with solid tumors and lymphomas | 1 |
| 10 | Pharmacodynamic profiling defines the significant biological activities of the novel proteasome inhibitor NPI-0052: Comparison with Velcade® (Bortezomib) | 1 |
| 11 | 49 | |
| 12 | 148 | |
| 13 | 72 | |
| 14 | 51 | |
| 15 | 34 | |
| 16 | 50 | |
| 17 | 31 | |
| 18 | 40 | |
| 19 | 114 | |
| 20 | 18 |
About G. Kenneth Lloyd
G. Kenneth Lloyd is a scholar working on Hematology, Pharmacology and Cellular and Molecular Neuroscience, having authored 80 papers that have together received 3.1k indexed citations. Recurring topics across this work include Nicotinic Acetylcholine Receptors Study (24 papers), Ubiquitin and proteasome pathways (21 papers) and Cholinesterase and Neurodegenerative Diseases (12 papers). The work is most often cited by research in Pharmacology (727 citations), Cellular and Molecular Neuroscience (728 citations) and Biotechnology (276 citations). G. Kenneth Lloyd has collaborated with scholars based in United States, Australia and Switzerland. Frequent co-authors include Michael Williams, Frédérique Menzaghi, Michael A. Palladino, Tadimeti S. Rao, Saskia Neuteboom, Barbara C. M. Potts, Aida Sacaan, Kin S. Lam, Jay S. Schneider and Julia Dunlop. Their work appears in journals such as Journal of Clinical Oncology, Blood and Nature Reviews Drug Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.